Intrinsic Value of S&P & Nasdaq Contact Us

Kali, Inc. KALY OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
26/100
0/3 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Kali, Inc. (KALY) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 23/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth ?/100 (Fail), Past 0/100 (Fail), Health 50/100 (Fail), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

KALY SharesGrow Score Overview

39/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 0/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.00005-0.0001
Volume16.4K
Avg Volume (30D)61.39K
Market Cap$50.91K
Beta (1Y)-72.35
Share Statistics
IPO Date2008-04-02
Employees171
CEOFrederick Ferri
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS4833801016

Price Chart

KALY
Kali, Inc.  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message